It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
There were 25 deaths among ivermectin users (0.8% mortality rate) and
79 deaths among non-ivermectin users (2.6% mortality rate), a 68% reduction in mortality rate (RR, 0.32; 95% CI, 0.20-0.49). When PSM was adjusted, reduction in mortality rate was 70% (RR, 0.30; 95% CI, 0.19-0.46; p < 0.0001).
This week was the period when deaths were supposed to be peaking – so given that no extra restrictions were ordered, it’s interesting to compare the peak the models predicted for this week with what actually happened.
Deaths were said by Sage to peak at anything from 600 to 6,000 a day (the latter figure, predictably, hogged the headlines). But on Saturday 262 deaths were reported in England, and the ONS indicates that a potentially large proportion of these were those who died from other causes but also happened to have Covid.
Hospitalisations were to peak between 3,000 to 10,000 a day.
But yesterday there were 1,698 hospital admissions and 14,320 patients in hospital (12 per cent fewer than last Saturday). We also know that about half of these patients are being primarily treated for something else, but also happen to have Covid.
The number of Covid patients in intensive care has fallen to a six-month low.
Presently, we offer the following services in all provinces except NL and PE:
1) Preventative Consultation (prophylaxis and/or “have on hand”) – $149
2) Early COVID-19 Treatment (less than 5 days since disease onset) – $299
3) Complex COVID-19 Treatment – your COVID-19 infection is advanced beyond 5 days – $399
We are a private COVID-19 (only) telehealth service, operate on a fee for service basis and are open to “members only”. The good news is that any Canadian who is willing to accept our reasonable membership responsibilities and commitments can become a member and receive the essential COVID-19 treatments they want or need.
As the pandemic continues and more variants emerge, it is more likely that people will be reinfected with COVID-19. Contact tracing and health protection work at UKHSA follows up people with a positive test result, whether they were a new case or a case of reinfection. However, surveillance figures only report COVID-19 cases as the date of the first infection, so individuals are only counted once.
UK public health agencies are now updating surveillance data to count infection episodes, including reinfection episodes. Infection episodes will be counted separately if there are at least 90 days between positive test results. Each episode begins with the earliest positive specimen date. If someone has another positive specimen within 90 days of the last one, this is included in the same episode. If they have another positive specimen more than 90 days after the last one, this is counted in a separate episode (a possible reinfection episode).
originally posted by: puzzled2
More papers are being published noting the helpful effects of using Ivermectin.
jan 15
Ivermectin Prophylaxis Used for COVID-19: A Citywide, Prospective, Observational Study of 223,128 Subjects Using Propensity Score Matching
There were 25 deaths among ivermectin users (0.8% mortality rate) and
79 deaths among non-ivermectin users (2.6% mortality rate), a 68% reduction in mortality rate (RR, 0.32; 95% CI, 0.20-0.49). When PSM was adjusted, reduction in mortality rate was 70% (RR, 0.30; 95% CI, 0.19-0.46; p < 0.0001).
Shame there was so much profiteering against thst treatment in the vulnerable